Brain metastases in disseminated germinal neoplasms: incidence and clinical course.
From July 1973, to March 1978, 139 patients with disseminated germinal neoplasms were treated with a variety of combination chemotherapy regimens. Twenty-one patients (15.1%) exhibited evidence of brain metastases at some time during their course. Central nervous system spread occurred somewhat more frequently in patients with choriocarcinoma and yolk sac histologies, although all types were at risk. This was a major cause of morbidity and mortality. However, central nervous system spread almost always occurred in patients with systemic relapse and thus did not affect overall survival. We have yet to identify a subgroup who potentially could benefit from prophylactic central nervous system therapy.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000517:prevention & control / Q000556:secondary* / Q000628:therapy; D002822:Choriocarcinoma / Q000556:secondary; D004407:Dysgerminoma / Q000556:secondary; D006801:Humans; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000556:secondary* / Q000628:therapy; D013724:Teratoma / Q000556:secondary; D013736:Testicular Neoplasms / Q000628:therapy
D000970:Antineoplastic Agents